Clinical Trial Update: CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC

View source ↗

Summary

The completed trial examines whether CT features of microvascular invasion can predict response to transarterial chemoembolization plus a tyrosine kinase inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tyrosine kinase inhibitors

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatocellular Carcinoma (HCC), Transarterial Chemoembolization | Status: COMPLETED